4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-002133
Director sold 9,671 shares at $76.82 ($742,942)
- Director acquired 9,671 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STONE HEISZ LESLIE · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-16 | Exercise or conversion : show line 1 in the form | +9,671 | $35.68 | $345,029 | 37,151 | D |
| 2023-02-16 | Sale : show line 2 in the form | −9,671 | $76.82 | $742,942 | 27,480 | D |
| Open-market sales · 9,671 sh · avg $76.82 · $742,942 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-02-16 | Exercise or conversion : show line 3 in the form Director Stock Option (Right to Acquire) | −9,671 | $35.68 | 2023-07-13 | 9,671 | 0 | D |
Loading xslF345X03/doc4.xml…